// App-Quantinova.ai

469 : The PPARα ligand, 10-hydroxyoctadecanoic acid, reduces facial pore size and pigmentation in normal skin

Researchers

Presenter

  • R. Schuetz

Principal Investigators

  • A.V. Rawlings

  • S. Trevisan

  • D. Imfeld

Medical Centers

  • Newtone Technologies, Lyon, Rhone-Alpes, France

Locations

  • Switzerland

  • United Kingdom

  • France

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • p53

  • Peroxisome proliferator activated receptor

  • Matrix metalloproteinase 1

  • Transepidermal water loss

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Placebo Control

  • Double Blind/Blinded

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved